Skip to main content
S&P 5007,722.72+0.73%DOW51,176.96+0.49%NASDAQ27,190.86+1.19%BTC$84,513.00-0.33%ETH$2,667.82-1.40%GOLD$4,172.10-0.72%OIL$91.26-1.73%
Smart Investors Daily
SID Premium
cbdMD, Inc. logo

NASDAQ · YCBD

cbdMD, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.45

Up+$0.01 (+1.22%)

Updated Oct 2, 2026, 11:41 PM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.58M
P/E ratio
-1.44
Dividend yield
0.00%
52-week range
$0.41 – $2.56
Volume
41.95K
Avg. volume
3.96M

Price performance · YCBD

YCBD price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 1, 2026

YCBD closed at $0.45 after 20 trading sessions, down 6.34% for the selected period.

Last close
$0.45
Period change
-6.34%
Period low
$0.44
Period high
$0.50
Daily close
View OHLC price history
YCBD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 1, 2026$0.45$0.46$0.44$0.450541.95K
Sep 30, 2026$0.47$0.47$0.4408$0.45389.7K
Sep 29, 2026$0.4564$0.47$0.451$0.46960.99K
Sep 28, 2026$0.4631$0.4715$0.45$0.463576.81K
Sep 25, 2026$0.448$0.4699$0.448$0.46836.8K
Sep 24, 2026$0.4449$0.4599$0.425$0.459151.87K
Sep 23, 2026$0.465$0.4721$0.4402$0.4574371.58K
Sep 22, 2026$0.432$0.50$0.41$0.502.4M
Sep 21, 2026$0.45$0.4602$0.4311$0.448.52M
Sep 18, 2026$0.511$0.58$0.45$0.45014.64M
Sep 17, 2026$0.4744$0.5125$0.4602$0.50787.79K
Sep 16, 2026$0.4611$0.4787$0.455$0.46648.78K
Sep 15, 2026$0.471$0.4766$0.46$0.4601112.49K
Sep 14, 2026$0.4765$0.4826$0.4765$0.477122.7K
Sep 11, 2026$0.4751$0.4919$0.4751$0.482213.29K
Sep 10, 2026$0.48$0.50$0.475$0.47871.62K
Sep 9, 2026$0.486$0.505$0.4745$0.491971.77K
Sep 8, 2026$0.4744$0.4998$0.4744$0.499734.36K
Sep 4, 2026$0.4796$0.4999$0.4746$0.475683.69K
Sep 3, 2026$0.481$0.4902$0.4521$0.481358.75K

Latest YCBD news

The latest Smart Investors Daily articles mentioning YCBD.

Stock researchCompany · Overview

YCBD research

Overview

Company profile and research snapshot.

Company profile

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
YCBD recent ratings
DateFirmRatingTarget
Aug 17, 2026Maxim GroupHold—
Aug 20, 2025Maxim GroupBuy—
May 22, 2025Maxim GroupBuy—
Oct 5, 2023Maxim GroupBuy—
Jun 18, 2021Cantor FitzgeraldNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 24, 2026

Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation

Reserveage, part of the Twinlab family of brands, announces the launch of Longev+, a new supplement available exclusively at The Vitamin Shoppe that brings muscle health and everyday performance into the healthy aging routine.* Offered in Mixed Berry stick packs, Longev+ combines essential amino acids, HMB, creatine and resveratrol to support adults seeking to stay strong, active and engaged through every stage of life.*

Yahoo · Sep 2, 2026

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness

cbdMD, Inc. (NYSE American: YCBD), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By